Ironwood Financial’s PDL BioPharma, Inc. PDLI Stock Holding History

Ironwood Financial’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,150	Closed	-$3K	–	382
2018 Q2	$3K	Hold	1,150	–	–	﹤0.01%	252
2018 Q1	$3K	Hold	1,150	–	–	﹤0.01%	225
2017 Q4	$3K	Hold	1,150	–	–	﹤0.01%	229
2017 Q3	$4K	Hold	1,150	–	–	﹤0.01%	230
2017 Q2	$3K	Hold	1,150	–	–	﹤0.01%	233
2017 Q1	$3K	Hold	1,150	–	–	﹤0.01%	235
2016 Q4	$2K	Hold	1,150	–	–	﹤0.01%	249
2016 Q3	$4K	Hold	1,150	–	–	﹤0.01%	223
2016 Q2	$4K	Hold	1,150	–	–	﹤0.01%	222
2016 Q1	$4K	Buy	+1,150	New	+$3.58K	﹤0.01%	225
2015 Q3	$6K	Hold	1,150	–	–	﹤0.01%	256
2015 Q2	$7K	Hold	1,150	–	–	﹤0.01%	227
2015 Q1	$8K	Hold	1,150	–	–	﹤0.01%	217
2014 Q4	$9K	Buy	+1,150	New	+$9.1K	0.01%	185

Other funds holding PDLI

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Ironwood Financial's PDLI Position: Q3 2018 in Review

Ironwood Financial sold out of PDL BioPharma, Inc. (PDLI) in Q3 2018, closing a stake of 1,150 shares — an estimated $3K sold.

Ironwood Financial first reported a position in PDLI in Q4 2014 and held it in 14 quarters. The position peaked at $9K in Q4 2014. 152 funds tracked by Wall St. Rank hold PDLI as of Q3 2018.

Ironwood Financial reported no remaining PDL BioPharma, Inc. position as of Q3 2018 after selling out during the quarter.
Ironwood Financial sold 1,150 PDL BioPharma, Inc. shares in Q3 2018, an estimated $3K.
Ironwood Financial first reported a position in PDL BioPharma, Inc. in Q4 2014 and held it in 14 quarters.
Ironwood Financial's PDL BioPharma, Inc. position peaked at $9K in Q4 2014.
152 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2018.

Based on Ironwood Financial's 13F filing for Q3 2018, filed 26 Oct 2018.